203 related articles for article (PubMed ID: 35304104)
1. Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis.
Bootsma BT; Plat VD; van de Brug T; Huisman DE; Botti M; van den Boezem PB; Bonsing BA; Bosscha K; Dejong CHC; Groot-Koerkamp B; Hagendoorn J; van der Harst E; de Hingh IH; de Meijer VE; Luyer MD; Nieuwenhuijs VB; Pranger BK; van Santvoort HC; Wijsman JH; Zonderhuis BM; Kazemier G; Besselink MG; Daams F;
Pancreatology; 2022 Apr; 22(3):421-426. PubMed ID: 35304104
[TBL] [Abstract][Full Text] [Related]
2. Octreotide and postoperative pancreatic fistula after pancreaticoduodenectomy: What we know so far? A narrative review.
Tilak M; Tewari M; Shukla HS
Indian J Cancer; 2023; 60(2):152-159. PubMed ID: 37530235
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin analogues and the risk of post-operative pancreatic fistulas after pancreatic resection - A systematic review & meta-analysis.
Li T; D'Cruz RT; Lim SY; Shelat VG
Pancreatology; 2020 Mar; 20(2):158-168. PubMed ID: 31980352
[TBL] [Abstract][Full Text] [Related]
4. Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? - A systematic review with meta-analysis of randomized-controlled trials.
Schorn S; Vogel T; Demir IE; Demir E; Safak O; Friess H; Ceyhan GO
Pancreatology; 2020 Dec; 20(8):1770-1778. PubMed ID: 33121847
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery.
Welsch T; Müssle B; Distler M; Knoth H; Weitz J; Häckl D
Langenbecks Arch Surg; 2016 Nov; 401(7):1027-1035. PubMed ID: 27233242
[TBL] [Abstract][Full Text] [Related]
6. A Propensity Score-Matched Analysis of Robotic vs Open Pancreatoduodenectomy on Incidence of Pancreatic Fistula.
McMillan MT; Zureikat AH; Hogg ME; Kowalsky SJ; Zeh HJ; Sprys MH; Vollmer CM
JAMA Surg; 2017 Apr; 152(4):327-335. PubMed ID: 28030724
[TBL] [Abstract][Full Text] [Related]
7. Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis.
Denbo JW; Slack RS; Bruno M; Cloyd JM; Prakash L; Fleming JB; Kim MP; Aloia TA; Vauthey JN; Lee JE; Katz MH
J Gastrointest Surg; 2017 Apr; 21(4):636-646. PubMed ID: 28050766
[TBL] [Abstract][Full Text] [Related]
8. Risk-stratified analysis of pasireotide for patients undergoing pancreatectomy.
Peng JS; Joyce D; Brady M; Groman A; Attwood K; Kuvshinoff B; Hochwald SN; Kukar M
J Surg Oncol; 2020 Aug; 122(2):195-203. PubMed ID: 32474957
[TBL] [Abstract][Full Text] [Related]
9. Influence of margin histology on development of pancreatic fistula following pancreatoduodenectomy.
Harrell KN; Jajja MR; Postlewait LM; Memis B; Maithel SK; Sarmiento JM; Adsay NV; Kooby DA
J Surg Res; 2020 Feb; 246():315-324. PubMed ID: 29754962
[TBL] [Abstract][Full Text] [Related]
10. Impact of pasireotide on postoperative pancreatic fistulas following distal resections.
Vuorela T; Mustonen H; Kokkola A; Haglund C; Seppanen H
Langenbecks Arch Surg; 2021 May; 406(3):735-742. PubMed ID: 33474568
[TBL] [Abstract][Full Text] [Related]
11. Pasireotide administration after pancreaticoduodenectomy may decrease clinically relevant postoperative pancreatic fistula in high-risk patients with small pancreatic ducts, soft pancreatic parenchyma and cystic or neuroendocrine neoplasia.
Vuorela T; Mustonen H; Kokkola A; Haglund C; Seppänen H
Pancreatology; 2020 Jun; 20(4):757-761. PubMed ID: 32307251
[TBL] [Abstract][Full Text] [Related]
12. The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials.
Adiamah A; Arif Z; Berti F; Singh S; Laskar N; Gomez D
World J Surg; 2019 Jul; 43(7):1788-1801. PubMed ID: 30798417
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of factors associated with post-operative pancreatic fistula following pancreatoduodenectomy.
Kamarajah SK; Bundred JR; Lin A; Halle-Smith J; Pande R; Sutcliffe R; Harrison EM; Roberts KJ;
ANZ J Surg; 2021 May; 91(5):810-821. PubMed ID: 33135873
[TBL] [Abstract][Full Text] [Related]
14. The value of serum amylase and drain fluid amylase to predict postoperative pancreatic fistula after pancreatoduodenectomy: a retrospective cohort study.
van Dongen JC; Merkens S; Aziz MH; Groot Koerkamp B; van Eijck CHJ
Langenbecks Arch Surg; 2021 Nov; 406(7):2333-2341. PubMed ID: 33990865
[TBL] [Abstract][Full Text] [Related]
15. Robotic versus open pancreatoduodenectomy: a propensity score-matched analysis based on factors predictive of postoperative pancreatic fistula.
Napoli N; Kauffmann EF; Menonna F; Costa F; Iacopi S; Amorese G; Giorgi S; Baggiani A; Boggi U
Surg Endosc; 2018 Mar; 32(3):1234-1247. PubMed ID: 28812160
[TBL] [Abstract][Full Text] [Related]
16. Video Grading of Pancreatic Anastomoses During Robotic Pancreatoduodenectomy to Assess Both Learning Curve and the Risk of Pancreatic Fistula: A Post Hoc Analysis of the LAELAPS-3 Training Program.
van den Broek BLJ; Zwart MJW; Bonsing BA; Busch OR; van Dam JL; de Hingh IHJT; Hogg ME; Luyer MD; Mieog JSD; Stibbe LA; Takagi K; Tran TCK; de Wilde RF; Zeh HJ; Zureikat AH; Groot Koerkamp B; Besselink MG;
Ann Surg; 2023 Nov; 278(5):e1048-e1054. PubMed ID: 36727842
[TBL] [Abstract][Full Text] [Related]
17. Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial.
Andrianello S; Marchegiani G; Malleo G; Masini G; Balduzzi A; Paiella S; Esposito A; Landoni L; Casetti L; Tuveri M; Salvia R; Bassi C
JAMA Surg; 2020 Apr; 155(4):313-321. PubMed ID: 32101272
[TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula.
Dalton EC; Johns MS; Rhodes L; Merritt WT; Petrelli NJ; Tiesi GJ
Am Surg; 2020 Dec; 86(12):1728-1735. PubMed ID: 32870029
[TBL] [Abstract][Full Text] [Related]
19. Risk Models for Developing Pancreatic Fistula After Pancreatoduodenectomy: Validation in a Nationwide Prospective Cohort.
Schouten TJ; Henry AC; Smits FJ; Besselink MG; Bonsing BA; Bosscha K; Busch OR; van Dam RM; van Eijck CH; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Kazemier G; Liem MSL; de Meijer VE; Patijn GA; Roos D; Schreinemakers JMJ; Stommel MWJ; Wit F; Daamen LA; Molenaar IQ; van Santvoort HC;
Ann Surg; 2023 Dec; 278(6):1001-1008. PubMed ID: 36804843
[TBL] [Abstract][Full Text] [Related]
20. Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy.
Ecker BL; McMillan MT; Asbun HJ; Ball CG; Bassi C; Beane JD; Behrman SW; Berger AC; Dickson EJ; Bloomston M; Callery MP; Christein JD; Dixon E; Drebin JA; Castillo CF; Fisher WE; Fong ZV; Haverick E; Hollis RH; House MG; Hughes SJ; Jamieson NB; Javed AA; Kent TS; Kowalsky SJ; Kunstman JW; Malleo G; Poruk KE; Salem RR; Schmidt CR; Soares K; Stauffer JA; Valero V; Velu LKP; Watkins AA; Wolfgang CL; Zureikat AH; Vollmer CM
Ann Surg; 2018 Apr; 267(4):608-616. PubMed ID: 28594741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
